文献
J-GLOBAL ID:202202253085359745
整理番号:22A0577642
miR-185-5pは,2つの標的化MyD88およびCXCR4を介してNLRP3インフラマソームの抑制によりCCI誘発性神経障害性疼痛を軽減する【JST・京大機械翻訳】
miR-185-5p alleviates CCI-induced neuropathic pain by repressing NLRP3 inflammasome through dual targeting MyD88 and CXCR4
著者 (5件):
Huang Airu
(Department of Rehabilitation Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, PR China)
,
Ji Ling
(Department of Rehabilitation Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, PR China)
,
Huang Yilong
(Gastrointestinal surgery, Pidu District People’s Hospital, Chengdu, Sichuan 611730, PR China)
,
Yu Qian
(Department of Rehabilitation Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, PR China)
,
Li Yufeng
(Department of Rehabilitation Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, PR China)
資料名:
International Immunopharmacology
(International Immunopharmacology)
巻:
104
ページ:
Null
発行年:
2022年
JST資料番号:
T0026B
ISSN:
1567-5769
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)